BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao XQ, Zhu WJ, Mou Y, Xu M, Xia JX. Dupilumab for treatment of severe atopic dermatitis accompanied by lichenoid amyloidosis in adults: Two case reports. World J Clin Cases 2023; 11(10): 2301-2307 [PMID: 37122507 DOI: 10.12998/wjcc.v11.i10.2301]
URL: https://www.wjgnet.com/2307-8960/full/v11/i10/2301.htm
Number Citing Articles
1
Benedetta Tirone, Gerardo Cazzato, Francesca Ambrogio, Caterina Foti, Marco Bellino. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic OptionDiseases 2024; 12(5): 94 doi: 10.3390/diseases12050094
2
Qin-Xiao Wang, Qian Ye, Kai-Yi Zhou, Si-Yu Luo, Sheng Fang. Systematic review and meta-analysis of treatments and outcomes in primary localized cutaneous amyloidosisClinical and Experimental Dermatology 2025;  doi: 10.1093/ced/llaf081
3
Feiying Guo, Huajie Zhong, Yuan Wu, Xue Xu, Jiarong Tan, Qiang Zhou, Shunli Tang. Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature reviewFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1485079